Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current status of stem cell therapy for liver diseases.
Souza BS, Nogueira RC, de Oliveira SA, de Freitas LA, Lyra LG, Ribeiro dos Santos R, Lyra AC, Soares MB. Souza BS, et al. Among authors: lyra lg, lyra ac. Cell Transplant. 2009;18(12):1261-79. doi: 10.3727/096368909X470522. Epub 2009 Aug 5. Cell Transplant. 2009. PMID: 19660179 Free article. Review.
Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
Lyra AC, Soares MB, da Silva LF, Fortes MF, Silva AG, Mota AC, Oliveira SA, Braga EL, de Carvalho WA, Genser B, dos Santos RR, Lyra LG. Lyra AC, et al. Among authors: lyra lg. World J Gastroenterol. 2007 Feb 21;13(7):1067-73. doi: 10.3748/wjg.v13.i7.1067. World J Gastroenterol. 2007. PMID: 17373741 Free PMC article. Clinical Trial.
Bone marrow stem cells and liver disease.
Lyra AC, Soares MB, dos Santos RR, Lyra LG. Lyra AC, et al. Among authors: lyra lg. Gut. 2007 Nov;56(11):1640; author reply 1640-1. Gut. 2007. PMID: 17938441 Free PMC article. No abstract available.
Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study.
Lyra AC, Soares MB, da Silva LF, Braga EL, Oliveira SA, Fortes MF, Silva AG, Brustolim D, Genser B, Dos Santos RR, Lyra LG. Lyra AC, et al. Among authors: lyra lg. Eur J Gastroenterol Hepatol. 2010 Jan;22(1):33-42. doi: 10.1097/MEG.0b013e32832eb69a. Eur J Gastroenterol Hepatol. 2010. PMID: 19654548 Clinical Trial.
Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B.
Angelo AL, Cavalcante LN, Abe-Sandes K, Machado TB, Lemaire DC, Malta F, Pinho JR, Lyra LG, Lyra AC. Angelo AL, et al. Among authors: lyra lg. Clinics (Sao Paulo). 2013 Oct;68(10):1325-32. doi: 10.6061/clinics/2013(10)06. Clinics (Sao Paulo). 2013. PMID: 24212839 Free PMC article.
Daily interferon induction regimen using different manufactured interferons (alpha-2A or alpha-2B) in combination with ribavirin for treatment of chronic hepatitis C: a prospective randomized study.
Braga EL, Lyra AC, Nascimento L, Netto E, Kalabrik L, Lyra LG. Braga EL, et al. Among authors: lyra lg, lyra ac. Arq Gastroenterol. 2006 Oct-Dec;43(4):275-9. doi: 10.1590/s0004-28032006000400006. Arq Gastroenterol. 2006. PMID: 17406754 Free article. Clinical Trial.
Crohn's disease in one mixed-race population in Brazil.
Santana GO, Lyra LG, Santana TC, Dos Reis LB, Guedes JC, Toralles MB, Lyra AC. Santana GO, et al. Among authors: lyra lg, lyra ac. World J Gastroenterol. 2007 Sep 7;13(33):4489-92. doi: 10.3748/wjg.v13.i33.4489. World J Gastroenterol. 2007. PMID: 17724806 Free PMC article.
46 results